Apotea AB (publ) (STO:APOTEA)
Sweden
· Delayed Price · Currency is SEK 87.13
-0.26 (-0.30%)
At close: Dec 4, 2025
Apotea AB Revenue
Apotea AB had revenue of 1.77B SEK in the quarter ending September 30, 2025, with 8.86% growth. This brings the company's revenue in the last twelve months to 7.09B, up 12.34% year-over-year. In the year 2024, Apotea AB had annual revenue of 6.55B with 20.01% growth.
Revenue (ttm)
7.09B
Revenue Growth
+12.34%
P/S Ratio
1.27
Revenue / Employee
9.79M
Employees
800
Market Cap
8.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.55B | 1.09B | 20.01% |
| Dec 31, 2023 | 5.46B | 572.40M | 11.72% |
| Dec 31, 2022 | 4.88B | 303.30M | 6.62% |
| Dec 31, 2021 | 4.58B | 1.74B | 61.34% |
| Dec 1, 2019 | 2.84B | 746.02M | 35.65% |
| Dec 1, 2018 | Pro | Pro | Pro |
| Dec 1, 2017 | Pro | Pro | Pro |
| Dec 1, 2016 | Pro | Pro | Pro |
| Dec 1, 2015 | Pro | Pro | Pro |
| Dec 1, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 27.85B |
| Getinge AB | 35.85B |
| Sectra AB | 3.37B |
| Camurus AB | 2.35B |
| Medicover AB | 25.67B |
| Asker Healthcare Group AB | 16.41B |
| BioArctic AB | 1.92B |
| AddLife AB | 10.53B |